Article info
PDFBrief communication
Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trial
- Correspondence to Prof. Frédéric Gagnadoux, Département de Pneumologie, CHU, Angers 49100, France; FrGagnadoux{at}chu-angers.fr
Citation
Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trial
Publication history
- Received September 16, 2018
- Accepted October 1, 2018
- First published October 26, 2018.
Online issue publication
April 11, 2019
Article Versions
- Previous version (26 October 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.